Home Infusion Therapy Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Home Infusion Therapy Market, By Product

7.1.  Home Infusion Therapy Market, by Product Type, 2020-2027

7.1.1.    Infusion Pumps

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Intravenous Sets

7.1.2.1.        Market Revenue and Forecast (2016-2027)

7.1.3.    IV Cannulas

7.1.3.1.        Market Revenue and Forecast (2016-2027)

7.1.4.    Needleless Connectors

7.1.4.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Home Infusion Therapy Market, By Application

8.1.  Home Infusion Therapy Market, by Application, 2020-2027

8.1.1.    Anti-infective

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Endocrinology

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Hydration Therapy

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Chemotherapy

8.1.4.1.        Market Revenue and Forecast (2016-2027)

8.1.5.    Enteral Nutrition

8.1.5.1.        Market Revenue and Forecast (2016-2027)

8.1.6.    Parenteral Nutrition

8.1.6.1.        Market Revenue and Forecast (2016-2027)

8.1.7.    Specialty Pharmaceuticals

8.1.7.1.        Market Revenue and Forecast (2016-2027)

8.1.8.    Others

8.1.8.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Home Infusion Therapy Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Product (2016-2027)

9.1.2.    Market Revenue and Forecast, by Application (2016-2027)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Product (2016-2027)

9.1.3.2.        Market Revenue and Forecast, by Application (2016-2027)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Product (2016-2027)

9.1.4.2.        Market Revenue and Forecast, by Application (2016-2027)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Product (2016-2027)

9.2.2.    Market Revenue and Forecast, by Application (2016-2027)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Product (2016-2027)

9.2.3.2.        Market Revenue and Forecast, by Application (2016-2027)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Product (2016-2027)

9.2.4.2.        Market Revenue and Forecast, by Application (2016-2027)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Product (2016-2027)

9.2.5.2.        Market Revenue and Forecast, by Application (2016-2027)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Product (2016-2027)

9.2.6.2.        Market Revenue and Forecast, by Application (2016-2027)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Product (2016-2027)

9.3.2.    Market Revenue and Forecast, by Application (2016-2027)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Product (2016-2027)

9.3.3.2.        Market Revenue and Forecast, by Application (2016-2027)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Product (2016-2027)

9.3.4.2.        Market Revenue and Forecast, by Application (2016-2027)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Product (2016-2027)

9.3.5.2.        Market Revenue and Forecast, by Application (2016-2027)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Product (2016-2027)

9.3.6.2.        Market Revenue and Forecast, by Application (2016-2027)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Product (2016-2027)

9.4.2.    Market Revenue and Forecast, by Application (2016-2027)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Product (2016-2027)

9.4.3.2.        Market Revenue and Forecast, by Application (2016-2027)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Product (2016-2027)

9.4.4.2.        Market Revenue and Forecast, by Application (2016-2027)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Product (2016-2027)

9.4.5.2.        Market Revenue and Forecast, by Application (2016-2027)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Product (2016-2027)

9.4.6.2.        Market Revenue and Forecast, by Application (2016-2027)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Product (2016-2027)

9.5.2.    Market Revenue and Forecast, by Application (2016-2027)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Product (2016-2027)

9.5.3.2.        Market Revenue and Forecast, by Application (2016-2027)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Product (2016-2027)

9.5.4.2.        Market Revenue and Forecast, by Application (2016-2027)

Chapter 10.  Company Profiles

10.1.              CVS/Coram

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Option Care Health

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              BriovaRx/Diplomat (UnitedHealth Optum)

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              PharMerica

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Fresenius Kabi

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              ICU Medical, Inc.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              B. Braun Melsungen AG

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Baxter

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              BD

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Caesarea Medical Electronics

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           Smiths Medical

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

10.12.           Terumo Corporation

10.12.1.               Company Overview

10.12.2.               Product Offerings

10.12.3.               Financial Performance

10.13.           JMS Co. Ltd.

10.13.1.               Company Overview

10.13.2.               Product Offerings

10.13.3.               Financial Performance

10.13.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms